Phaseline

Targets › SORT1

SORT1 (Sortilin): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Oncology.

Functions as a sorting receptor in the Golgi compartment and as a clearance receptor on the cell surface. Required for protein transport from the Golgi apparatus to the lysosomes by a pathway that is independent of the mannose-6-phosphate receptor (M6PR). (UniProt, Q99523)

Open in Phaseline: the race on SORT1, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
TheratechnologiesTH1902
SORT1-targeted peptide-drug conjugate
SORT1Phase 1Solid Tumor–

Conditions

Solid Tumor (1)

Modalities

protein or peptide (1)

Companies

Theratechnologies (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.